AM10559PU-N
antibody from Acris Antibodies GmbH
Targeting: FOLH1
FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AM10559PU-N - Provider product page
- Provider
- Acris Antibodies GmbH
- Product name
- anti PSMA / FOLH1
- Antibody type
- Monoclonal
- Antigen
- Purified recombinant Human PSMA protein
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- SCPSMA
- Vial size
- 0.1 ml
- Concentration
- 1 mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Figure 1. Western blot of LNCaP cell lysates using PSMA/FOLH1 Antibody Cat.-No AM10559PU-N (Clone SCPSMA). LNCaP cell lysates (5 µg) was separated and blotted onto PVDF membrane followed by incubating with anti-PSMA mAb. The antibody can specifically detect the endogenous PSMA as well as recombinant PSMA (data not shown).
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Figure 3. Staining of FFPE Human neoplastic tubular prostatic cancer (10x and 40x) with PSMA/FOLH1 Antibody Cat.-No AM10559PU-N (Clone SCPSMA) at 2 µg/ml. Antibody positive in the cytoplasm of epithelial cells.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Figure 2. Flow Cytometric analysis of PSMA expression on the LNCaP cells using PSMA/FOLH1 Antibody Cat.-No AM10559PU-N (Clone SCPSMA). The left peak: LNCaP cells only without anti-PSMA antibody; the right peak: LNCaP cells were incubated with anti-PSMA antibody followed with fluorescence-labeled detection antibody. Strong interaction between anti-PSMA mAb and PSMA on the LNCaP cell surface were detected.